Zimmer Biomet Holdings Company Profile (NYSE:ZMH)

About Zimmer Biomet Holdings (NYSE:ZMH)

Zimmer Biomet Holdings logoZimmer Biomet Holdings, Inc. is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company's products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas, consisting principally of the United States and other North, Central and South American markets; EMEA, consisting principally of Europe and the Middle East and African markets, and Asia Pacific, consisting primarily of Japan and other Asian and Pacific markets. The Company's product category segments include Americas Spine, Office Based Technologies, Craniomaxillofacial and Thoracic (CMF), and Dental.

Industry, Sector and Symbol:
  • Sector:
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: NYSE:ZMH
  • CUSIP: N/A
  • Web: N/A
Average Prices:
  • 50 Day Moving Avg: $113.34
  • 200 Day Moving Avg: $115.50
  • 52 Week Range: $94.73 - $121.84
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 16.41
  • P/E Growth: 0.00
Misc:
  • Average Volume: 1.13 million shs.
 

Frequently Asked Questions for Zimmer Biomet Holdings (NYSE:ZMH)

What is Zimmer Biomet Holdings' stock symbol?

Zimmer Biomet Holdings trades on the New York Stock Exchange (NYSE) under the ticker symbol "ZMH."

Who are some of Zimmer Biomet Holdings' key competitors?

Who are Zimmer Biomet Holdings' key executives?

Zimmer Biomet Holdings' management team includes the folowing people:

  • David C. Dvorak, President, Chief Executive Officer, Director
  • Daniel P. Florin, Chief Financial Officer, Senior Vice President
  • Robert D. Delps, President, Americas
  • Katarzyna Mazur-Hofsaess M.D. Ph.D., President, Europe, Middle East and Africa
  • Sang Yi, President, Asia Pacific
  • Chad F. Phipps, Senior Vice President, General Counsel, Secretary
  • Larry C. Glasscock, Independent Non-Executive Chairman of the Board
  • Christopher B. Begley, Independent Director
  • Betsy J. Bernard, Independent Director
  • Gail Koziara Boudreaux, Independent Director

How do I buy Zimmer Biomet Holdings stock?

Shares of Zimmer Biomet Holdings can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Zimmer Biomet Holdings' stock price today?

One share of Zimmer Biomet Holdings stock can currently be purchased for approximately $113.56.


MarketBeat Community Rating for Zimmer Biomet Holdings (NYSE ZMH)
Community Ranking:  2.5 out of 5 (  )
Outperform Votes:  6 (Vote Outperform)
Underperform Votes:  6 (Vote Underperform)
Total Votes:  12
MarketBeat's community ratings are surveys of what our community members think about Zimmer Biomet Holdings and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Zimmer Biomet Holdings (NYSE:ZMH) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: N/A

Analysts' Ratings History for Zimmer Biomet Holdings (NYSE:ZMH)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
8/10/2016SunTrust Banks, Inc.Initiated CoverageBuyN/AView Rating Details
1/7/2016Northland SecuritiesDowngradeOutperform -> Market PerformN/AView Rating Details
12/3/2015Royal Bank of CanadaReiterated RatingOutperform$136.00 -> $125.00N/AView Rating Details
12/3/2015Deutsche Bank AGReiterated RatingHold$107.00 -> $114.00N/AView Rating Details
(Data available from 5/30/2015 forward)

Earnings

Earnings History for Zimmer Biomet Holdings (NYSE:ZMH)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Zimmer Biomet Holdings (NYSE:ZMH)
Current Year EPS Consensus Estimate: $6.36 EPS
Next Year EPS Consensus Estimate: $6.92 EPS

Dividends

Dividend History for Zimmer Biomet Holdings (NYSE:ZMH)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Zimmer Biomet Holdings (NYSE:ZMH)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Zimmer Biomet Holdings (NYSE:ZMH)
Latest Headlines for Zimmer Biomet Holdings (NYSE:ZMH)
Source:
DateHeadline
finance.yahoo.com logoJohnson & Johnson’s Medical Devices Segment
finance.yahoo.com - May 15 at 7:54 PM
prnewswire.com logoZimmer Biomet Holdings to Present at the Bank of America Merrill Lynch 2017 Health Care Conference
www.prnewswire.com - May 8 at 8:02 AM
investopedia.com logoZimmer Biomet Stock Trades Ex-Dividend Wednesday (ZBH)
www.investopedia.com - March 29 at 8:15 AM
finance.yahoo.com logoShoulder Replacement Lawsuit Attorneys at Bernstein Liebhard LLP Investigating Potential Legal Claims …
finance.yahoo.com - February 24 at 8:06 AM
feeds.benzinga.com logoZimmer Biomet Delivers An Encouraging Bounce-Back In Q4
feeds.benzinga.com - February 1 at 12:29 PM
zacks.com logoZimmer Biomet (ZBH): Tops Q4 Earnings Estimates, Meets Sales
www.zacks.com - January 31 at 8:16 AM
nasdaq.com logoZimmer Biomet Holdings Inc. Reveals 1% Advance In Q4 Earnings
www.nasdaq.com - January 31 at 8:16 AM
businesswire.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Zimmer Biomet Holdings, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 31, 2017
www.businesswire.com - January 24 at 9:03 PM
reuters.com logoZimmer Biomet to pay $30.5 million to resolve U.S. bribery probe
www.reuters.com - January 13 at 8:34 PM
finance.yahoo.com logoZimmer Biomet Prices Offering of Euro-Denominated Senior Notes
finance.yahoo.com - January 13 at 8:34 PM
finance.yahoo.com logoZimmer Biomet Strengthens Spine Offering with PrimaGen Advanced™ Allograft
finance.yahoo.com - January 13 at 8:34 PM
finance.yahoo.com logoZimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2016
finance.yahoo.com - January 13 at 8:34 PM
prnewswire.com logoZimmer Biomet Announces Resolution with DOJ and SEC Regarding Previously Disclosed Legacy Biomet FCPA Matters
www.prnewswire.com - January 13 at 7:52 AM
streetinsider.com logoZimmer Biomet Holdings (ZBH) Resolves Legacy Biomet FCPA Matters with DOJ and SEC
www.streetinsider.com - January 13 at 7:52 AM
forbes.com logoTuesday Sector Leaders: Healthcare, Services
www.forbes.com - January 10 at 3:39 PM
finance.yahoo.com logoZimmer Biomet (ZBH): Spine Group Solid, Q3 Results a Drag
finance.yahoo.com - December 20 at 8:51 AM
reuters.com logoZimmer Biomet to settle bribery charges with U.S. prosecutors: filing
www.reuters.com - December 8 at 8:22 PM
reuters.com logoBRIEF-Zimmer Biomet prices offering of euro-denominated senior notes
www.reuters.com - December 7 at 2:19 AM
finance.yahoo.com logoZimmer Biomet Announces the Early Tender Results and Upsizing of Its Cash Tender Offers for Certain Outstanding Debt Securities
finance.yahoo.com - December 6 at 8:00 AM
finance.yahoo.com logoZIMMER BIOMET (ZBH) ALERT: Johnson & Weaver, LLP Announces Filing of Class Action Complaint Against Zimmer …
finance.yahoo.com - December 3 at 7:38 PM
nasdaq.com logoZimmer Biomet Cuts Forecasts -- Update
www.nasdaq.com - November 1 at 12:22 PM
biz.yahoo.com logoZimmer Biomet Holdings Inc Earnings Call (Q3 2016)
biz.yahoo.com - November 1 at 12:22 PM

Social

Chart

Zimmer Biomet Holdings (ZMH) Chart for Tuesday, May, 30, 2017

This page was last updated on 5/30/2017 by MarketBeat.com Staff